Becomes drug development partner with top global vaccine manufacturer
Thursday, February 2, 2012
When you buy Microsoft products, you are now promoting the pharmaceutical industry and its global vaccine agenda. That’s the new reality in which we live, where the world’s largest software company is “in bed” with the world’s largest vaccine pusher.
How so? In 2009, Microsoft purchased a key piece of technology from the drug company Merck, the world’s largest maker of vaccines (which Bill Gates says can help “reduce the global population” by 10 to 15 percent). That technology, as you’ll see below, can conceivably be used to develop eugenics vaccines that target specific races and nationalities with infertility-inducing pharmaceuticals — something that is entirely consistent with Bill Gates’ openly-admitted goal of reducing world population through the use of vaccines (see link to video below).
This gene-targeting vaccine research technology purchased by Microsoft was developed by the company known as Rosetta Biosciences, formerly owned by Merck. Their software is described as a way to “figure out how genes interact with each other, analyze peptides and metabolites, and determine how they relate to gene expression.” (http://seattletimes.nwsource.com/html/microsoft/2009288622_rosetta020…)
An announcement on the Rosetta Biosoftware web site explains, “The deal allows Microsoft to incorporate genetic, genomic, metabolomic and proteomics data management software into the Microsoft Amalga Life Sciences platform for enhanced translational research capabilities.” (http://www.rosettabio.com/company/news/rosetta_microsoft)
This same announcement goes on to say that vaccine maker Merck will “provide strategic input to Microsoft” as a part of the deal. Merck’s strategy, of course, is to make money by pimping vaccines and pharmaceuticals, including the now-infamous Gardasil vaccine.
Rupert Vessey, the vice president of Merck Research Laboratories, openly admits this deal puts Microsoft in the role of being a drug developer. He says, “We look forward to collaborating with Microsoft to develop new bioinformatic solutions to enable and expedite drug discovery and development…”
This is a key statement to understand, because the term “bioinformatic” can only mean one thing. What stores information in biology? These is only one digital storage system in human biology, and that system is, of course, DNA. Therefore, the idea of developing “bioinformatic solutions” really means to develop “gene-targeting drugs and vaccines.”
This is fully consistent with Bill Gates’ admitted agenda of reducing world population with the help of drug company technologies. At a TED conference, he announced in front of a live audience:“…if we do a really great job on new vaccines, health care, reproductive health services, we could lower [global population] by perhaps 10 or 15 percent.”(http://www.naturalnews.com/029911_vaccines_Bill_Gates.html)
See the video yourself at:
All this comes on the heels of other recent news that Bill Gates is fundingsperm-destroying technologyto cause widespread male infertility (http://www.naturalnews.com/034834_Bill_Gates_sperm_infertility.html). His foundation has also funded genetically modified mosquitoes and other mad science experiments (http://www.naturalnews.com/030940_Bill_Gates_Foundation_genetics.html).
Microsoft the new leader in eugenics technology?
What’s clear from all this is that Bill Gates is pursuing an agenda of human depopulation. This is a similar agenda of those who pursueeugenicsefforts around the globe, including Adolf Hitler and a long list of former FDA Commissioners in the United States. One of the most common ambitions of those in the highest positions of power, it seems, is to cull the human population and eliminate “the little people,” leaving only a “master race” of supreme beings.
Even major universities around the globe are now teaching students that human beings are evil for merely being alive and exhaling carbon dioxide, and that killing off humans is “green” for the planet.
In order to kill off large swaths of human beings, the most efficient mechanism to use is a self-replicating, gene-targeted bioweapon. Microsoft’s Amalga Life Sciences technology, purchased from vaccine developer March, theoretically provides a viable platform to develop precisely such bioweapons. It is interesting that no announcements from the company appear to have been made since being acquired by Microsoft in 2009, indicating that their work is now being conducted in total secrecy, behind closed doors.
U.S. government admits developing weaponized, deadly flu strains
Recent headlines reveal that the United States government has also secretly funded bioweapons research that resulted in the development of super-deadly flu strains that could wipe out far more than just 15 percent of the human population. As revealed in recent news headlines:
“Scientists agreed Friday to a 60-day moratorium on research into a modified avian flu virus that has been demonstrated to be more transmissible among mammals. Although the investigators believe their research has a public health benefit, they acknowledge the fear of some governments and others that the genetically altered virus could escape from labs and infect people.”(http://www.philly.com/philly/health/news/HealthDay660965_20120120_Res…)
That may be precisely the point, it turns out. There is no better way to promote the vaccine profits of the pharmaceutical industry than to actually release an engineered bioweapon virus into the wild. And there is no faster way to reduce the world population than to engineer either a vaccine or a weaponized flu virus that burns through the human population, targeting those of an “undesirable” genetic profile who need to be “cleansed” from the human gene pool.
This about this the next time you think about purchasing Microsoft Office, Windows or some other Microsoft product. By doing so, you are funding what could very well be a global eugenics agenda with the ultimate goal of wiping out a significant proportion of the human race.
This article was posted: Thursday, February 2, 2012 at 4:30 am